Clinicopathological Significance of BRAF(V600E) Mutation in Colorectal Cancer: An Updated Meta-Analysis

Background and Aims: Numerous studies have identified BRAF(V600E) mutation as a predictive factor of anti-EGFR antibodies in colorectal cancer (CRC). However, the association between BRAF(V600E) mutation and clinicopathological features remains unclear. Therefore, we aimed to conduct an updated and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianhua, Shen, Jiajia, Huang, Chi, Cao, Meng, Shen, Lizong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584400/
https://www.ncbi.nlm.nih.gov/pubmed/31258736
http://dx.doi.org/10.7150/jca.30789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584400/
https://www.ncbi.nlm.nih.gov/pubmed/31258736
http://dx.doi.org/10.7150/jca.30789

Ejemplares similares